Clinical Trial Update: The Effect of Buccal Infiltration Administration of Clonidine on the Success Rate of Inferior Alveolar Nerve Block [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating buccal infiltration of clonidine to improve success rate of inferior alveolar nerve block was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Irreversible Pulpitis

Drugs mentioned

• Clonidine (clonidine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Symptomatic Irreversible Pulpitis | Phase 4 | Status: WITHDRAWN